Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Isabel Arrillaga-Romany, M.D.

Concepts (151)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Isabel Arrillaga-Romany's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Isabel Arrillaga-Romany has written about over time.
Angiogenesis Inhibitors, 3 publications between 2013 and 2021, average publication date August 2016. Neurotoxicity Syndromes, 5 publications between 2012 and 2023, average publication date May 2017. Antigens, CD19, 1 publications between 2017 and 2017, average publication date August 2017. Lymphoma, Large B-Cell, Diffuse, 1 publications between 2017 and 2017, average publication date August 2017. Receptors, Antigen, T-Cell, 1 publications between 2017 and 2017, average publication date August 2017. Antineoplastic Agents, 8 publications between 2012 and 2023, average publication date October 2017. Brain Diseases, 1 publications between 2019 and 2019, average publication date January 2019. Critical Pathways, 1 publications between 2019 and 2019, average publication date January 2019. Imidazoles, 2 publications between 2018 and 2020, average publication date June 2019. Pyrimidines, 2 publications between 2018 and 2020, average publication date June 2019. Receptors, Dopamine D5, 2 publications between 2018 and 2020, average publication date June 2019. Glioblastoma, 9 publications between 2013 and 2023, average publication date July 2019. Neoplasm Recurrence, Local, 4 publications between 2019 and 2021, average publication date February 2020. Brain Neoplasms, 14 publications between 2013 and 2023, average publication date March 2020. Pyridines, 3 publications between 2018 and 2023, average publication date September 2020. Proto-Oncogene Proteins B-raf, 1 publications between 2021 and 2021, average publication date February 2021. Isocitrate Dehydrogenase, 6 publications between 2018 and 2023, average publication date March 2021. Glioma, 9 publications between 2018 and 2023, average publication date November 2021. Central Nervous System Neoplasms, 2 publications between 2021 and 2023, average publication date July 2022.

To see the data from this visualization as text, click here.
Arrillaga-Romany's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (151)
Explore
_
Co-Authors (95)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.